Page last updated: 2024-11-12
hupc protein, bacteria
Description
hupC protein, Bacteria: from structural operon of Rhizobium leguminosarum bv. viciae; MW 27.9 kDa; has hydrogenase activity; amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 10198698 |
| CHEMBL ID | 2409142 |
| SCHEMBL ID | 17278937 |
| MeSH ID | M0202031 |
Synonyms (12)
| Synonym |
|---|
| protein (rhizobium leguminosarum viceae clone palw8 gene hupc) |
| hydrogenase b-type cytochrome subunit hupc protein, bacteria |
| protein (rhizobium leguminosarum viceae clone palw8 gene hupc reduced) |
| 147416-32-8 |
| hupc protein, bacteria |
| CHEMBL2409142 |
| SCHEMBL17278937 |
| hupc protein |
| (5r,9r,11r)-5-amino-7-methyl-11-vinyl-5,6,9,10-tetrahydro-5,9-methanocycloocta[b]pyridin-2(1h)-one |
| (1r,9r,13r)-1-amino-13-ethenyl-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one |
| HY-122957 |
| CS-0090709 |
Protein Targets (1)
Inhibition Measurements
Biological Processes (14)
Molecular Functions (10)
Ceullar Components (13)
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID763022 | Mixed-type competitive inhibition of rat cortical AChE by Lineweaver-Burke plot analysis | 2013 | Journal of natural products, Aug-23, Volume: 76, Issue:8
| Casuarinines A-J, lycodine-type alkaloids from Lycopodiastrum casuarinoides. |
| AID763025 | Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate after 8 mins by Ellman's spectrophotometric method | 2013 | Journal of natural products, Aug-23, Volume: 76, Issue:8
| Casuarinines A-J, lycodine-type alkaloids from Lycopodiastrum casuarinoides. |
| AID763024 | Reversible inhibition of rat cortical AChE up to 8 mins | 2013 | Journal of natural products, Aug-23, Volume: 76, Issue:8
| Casuarinines A-J, lycodine-type alkaloids from Lycopodiastrum casuarinoides. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.55
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.55 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.63 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |